Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma

被引:47
|
作者
Yu, JunJie [1 ]
Mao, WeiPu [1 ]
Sun, Si [1 ]
Hu, Qiang [1 ]
Wang, Can [1 ]
Xu, ZhiPeng [1 ]
Liu, RuiJi [1 ]
Chen, SaiSai [1 ]
Xu, Bin [2 ]
Chen, Ming [2 ,3 ]
机构
[1] Southeast Univ, Coll Med, Nanjing, Peoples R China
[2] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing, Peoples R China
[3] Southeast Univ, Dept Urol, Affiliated Lishui Peoples Hosp, Nanjing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
prognostic signature; The Cancer Genome Atlas; long non-coding RNA; kidney renal clear cell carcinoma; M6A; PARTIAL NEPHRECTOMY; NONCODING RNAS; EXPRESSION; CANCER;
D O I
10.3389/fonc.2021.663263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to construct an m6A-related long non-coding RNAs (lncRNAs) signature to accurately predict the prognosis of kidney clear cell carcinoma (KIRC) patients using data obtained from The Cancer Genome Atlas (TCGA) database. Methods The KIRC patient data were downloaded from TCGA database and m6A-related genes were obtained from published articles. Pearson correlation analysis was implemented to identify m6A-related lncRNAs. Univariate, Lasso, and multivariate Cox regression analyses were used to identifying prognostic risk-associated lncRNAs. Five lncRNAs were identified and used to construct a prognostic signature in training set. Kaplan-Meier curves and receiver operating characteristic (ROC) curves were applied to evaluate reliability and sensitivity of the signature in testing set and overall set, respectively. A prognostic nomogram was established to predict the probable 1-, 3-, and 5-year overall survival of KIRC patients quantitatively. GSEA was performed to explore the potential biological processes and cellular pathways. Besides, the lncRNA/miRNA/mRNA ceRNA network and PPI network were constructed based on weighted gene co-expression network analysis (WGCNA). Functional Enrichment Analysis was used to identify the biological functions of m6A-related lncRNAs. Results We constructed and verified an m6A-related lncRNAs prognostic signature of KIRC patients in TCGA database. We confirmed that the survival rates of KIRC patients with high-risk subgroup were significantly poorer than those with low-risk subgroup in the training set and testing set. ROC curves indicated that the prognostic signature had a reliable predictive capability in the training set (AUC = 0.802) and testing set (AUC = 0.725), respectively. Also, we established a prognostic nomogram with a high C-index and accomplished good prediction accuracy. The lncRNA/miRNA/mRNA ceRNA network and PPI network, as well as functional enrichment analysis provided us with new ways to search for potential biological functions. Conclusions We constructed an m6A-related lncRNAs prognostic signature which could accurately predict the prognosis of KIRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients
    Wang, Jun-Mei
    Li, Xuan
    Yang, Peng
    Geng, Wen-Bin
    Wang, Xiao-Yong
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [2] Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients
    Jun-Mei Wang
    Xuan Li
    Peng Yang
    Wen-Bin Geng
    Xiao-Yong Wang
    BMC Gastroenterology, 22
  • [3] An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
    Zhang, Zhenyu
    Wang, Fangkai
    Zhang, Jianlin
    Zhan, Wenjing
    Zhang, Gaosong
    Li, Chong
    Zhang, Tongyuan
    Yuan, Qianqian
    Chen, Jia
    Guo, Manyu
    Xu, Honghai
    Yu, Feng
    Wang, Hengyi
    Wang, Xingyu
    Kong, Weihao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [4] Identification of m6A-Related lncRNA to Predict the Prognosis of Patients with Hepatocellular Carcinoma
    Yang, Hao
    Yang, Hong
    Zhang, Wei
    Wang, Juping
    Sun, Liping
    Gao, Juan
    Zhao, Haiping
    Wang, Zhenfei
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [5] m6A-related lncRNA signature for predicting prognosis and immune response in head and neck squamous cell carcinoma
    Yin, Ji
    He, Xinling
    Qin, Fengfeng
    Zheng, Sihan
    Huang, Yanlin
    Hu, Lanxin
    Chen, Yuxiang
    Zhong, Lunkun
    Hu, Wenjian
    Li, Sen
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (11): : 7653 - +
  • [6] Identification of a lactate metabolism-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
    Xu, Tianzi
    Liu, Yixin
    Ning, Biao
    Luo, Min
    Wei, Yongchang
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (04) : 509 - 525
  • [7] Identification and validation of an m5C-related lncRNA signature for predicting prognosis and immune response in clear cell renal cell carcinoma
    Shan Ao
    Leqi Liang
    Lei Peng
    Riwei Yang
    Zugen Chen
    Tuo Deng
    Discover Oncology, 16 (1)
  • [8] Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
    Zhang, Yue
    Zhuang, Tongtian
    Xin, Zhenlong
    Sun, Changjian
    Li, Deyang
    Ma, Nan
    Wang, Xiaoyan
    Wang, Xuning
    CELLS, 2023, 12 (01)
  • [9] A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma
    Shen, Yefeng
    Wang, Shaochun
    Wu, Yuanzhou
    CELLS, 2022, 11 (15)
  • [10] Development and validation of a m6A-related gene signature for predicting the prognosis of hepatocellular carcinoma
    Kong, Weihao
    Li, Xutong
    Xu, Honghai
    Gao, Yufeng
    BIOMARKERS IN MEDICINE, 2020, 14 (13) : 1217 - 1228